课题基金 / 基金详情

Molecular pathological analysis of citrullinated proteins in the brain from neurodegenerative disorder patients.

Molecular pathological analysis of citrullinated proteins in the brain from neurodegenerative disorder patients.
神经退行性疾病患者大脑中瓜氨酸蛋白的分子病理学分析。
批准号:
14570210
负责人:
ISHIGAMI Akihito
金额:
$2.11万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2004

项目摘要

项目成果

ISHIGAMI Akihito的其他基金

相似基金

相关文献

中文摘要
翻译
瓜氨酸化蛋白是翻译后过程的产物,其中当被肽基精氨酸脱亚胺酶(PAD)以钙离子依赖性方式催化时,精氨酸残基经历修饰成瓜氨酸残基。酶促瓜氨酸消除天然蛋白质分子的正电荷,不可避免地导致其结构和功能的显著改变。在哺乳动物组织中,PAD被发现为五种不同的同种型(即,1- 4,6型)。PAD 2主要表达于大鼠大脑,在神经退行性变的早期被激活。为了阐明瓜氨酸在神经元变性中的作用,我们检测了瓜氨酸化蛋白是否在阿尔茨海默病(AD)、帕金森病和亨廷顿舞蹈病中产生。1.组织化学分析显示,在海马各处都检测到瓜氨酸化蛋白。然而,在正常海马中未检测到瓜氨酸化蛋白。在AD和正常脑中,PAD 2免疫反应也在整个海马中检测到。双重免疫荧光染色显示瓜氨酸蛋白和PAD 2阳性细胞与GFAP阳性细胞有很好的一致性,但并非所有GFAP阳性细胞都是PAD 2阳性细胞。由于胶质纤维酸性蛋白是星形胶质细胞特异性标志蛋白,因此PAD 2主要分布于星形胶质细胞。2. Western blot检测AD海马组织中存在不同分子量的瓜氨酸化蛋白,而正常脑组织中无瓜氨酸化蛋白。其中两种瓜氨酸化蛋白被鉴定为波形蛋白(vimentin)和胶质细胞酸性蛋白(GFAP),因此,AD海马中存在瓜氨酸化蛋白的异常积累和PAD 2的异常激活。提示PAD在AD的发生、发展中起重要作用,瓜氨酸化蛋白可能成为神经退行性疾病的一个有用的标志物。
英文摘要
Citrullinated proteins are the products of a post-translational process in which arginine residues undergo modification into citrulline residues when catalyzed by peptidylarginine deiminases(PADs) in a calcium ion-dependent manner. Enzymatic citrullination abolishes positive charges of native protein molecules, inevitably causing significant alterations in their structure and functions. In mammalian tissues, PADs are found as five different isoforms (i.e, types 1-4,6). PAD2 expressed mainly in the rat cerebrum became activated early in the neurodegenerative process. To elucidate the involvement of the citrullination in neuronal degeneration, we examined whether citrullinated proteins are produced in Alzheimer's disease(AD), Parkinson's disease, and Huntington chorea.1.Histochemical analysis revealed that citrullinated proteins were detected all over the hippocampus. However, no citrullinated proteins were detected in the normal hippocampus. PAD2 immunoreactivity was also detected all over the hippocampus both in the AD and the normal brain. Double immunofluorescence staining revealed that citrullinated protein- and PAD2-positive cells were well-coinddenced with GFAP-positive cells, but not all GFAP-positive cells were PAD2-positive cells. As GFAP is a astrocyte-spedfic marker protein, PAD2 is distributed mainly in astrocytes.2.Citrullinated proteins with various molecular weight were detected in AD hippocampus by Western blot analysis, but not in normal brain. Two of the citrullinated proteins were identified as a vimentin and a glial fibrillary acidic protein(GFAP).Thus, abnormal accumulation of citrullinated proteins and abnormal activation of PAD2 is occurring in AD hippocampus. These results strongly suggested that PAD has an important role in the onset and progression of AD and citrullinated proteins may became a possible useful marker for human neurodegenerative disease.
期刊论文(39)
专著(0)
科研奖励(0)
会议论文
Protein deimination and peptidylarginine deiminase expression during cornification of rat epidermal keratinocytes.
大鼠表皮角质形成细胞角质化过程中的蛋白质脱亚胺化和肽基精氨酸脱亚胺酶表达。
DOI: --
发表时间: 2002
期刊: Biomed.Res. 23
影响因子: --
作者: [Ishigami, A., Asaga, H., et al.]
通讯作者: et al.
DOI: 10.1016/j.exger.2004.04.005
发表时间: 2004-08-01
期刊: EXPERIMENTAL GERONTOLOGY
影响因子: 3.9
作者: [Jung, KJ, Ishigami, A, Chung, HY]
通讯作者: Chung, HY
DOI: 10.1016/j.bbrc.2004.01.091
发表时间: 2004-03-12
期刊: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
影响因子: 3.1
作者: [Ishigami, A, Kondo, Y, Maruyama, N]
通讯作者: Maruyama, N
Senescence marker protein-30 (SMP30) regulates Akt activity and contributes to cell survival in Hep G2 cells.
衰老标记蛋白 30 (SMP30) 调节 Akt 活性并有助于 Hep G2 细胞的细胞存活。
DOI: --
发表时间: 2004
期刊: Biochem.Biophys.Res.Commun. 321
影响因子: --
作者: [Matsuyama, S., Kitamura, T., Enomoto, N., Fujita, T.et al.]
通讯作者: T.et al.
共 17 条
    Development of diagnostic agent for dementia
    Effect of vitamin C deficiency on the fetal growth and aging
    Pathogenesis and drug development using a mouse model of chronic obstructive pulmonary disease
    The elucidation of onset mechanism of Alzheimer's disease.
    • 批准号:
      18590355
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.5万
    • 财政年份:
      2006
    • 负责人:
      ISHIGAMI Akihito
    • 依托单位:
    国内基金
    海外基金
    新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
    • 批准号:
      81000622
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      20.0万元
    • 批准年份:
      2010
    • 负责人:
      梁胜
    • 依托单位:
    阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
    • 批准号:
      31060293
    • 项目类别:
      地区科学基金项目
    • 资助金额:
      26.0万元
    • 批准年份:
      2010
    • 负责人:
      郭亚芬
    • 依托单位:
    跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究